KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Inventory (2016 - 2025)

Boston Scientific's Inventory history spans 17 years, with the latest figure at $2.9 billion for Q4 2025.

  • For Q4 2025, Inventory rose 4.73% year-over-year to $2.9 billion; the TTM value through Dec 2025 reached $2.9 billion, up 4.73%, while the annual FY2025 figure was $2.9 billion, 4.73% up from the prior year.
  • Inventory for Q4 2025 was $2.9 billion at Boston Scientific, up from $2.9 billion in the prior quarter.
  • Across five years, Inventory topped out at $2.9 billion in Q4 2025 and bottomed at $1.4 billion in Q2 2021.
  • The 5-year median for Inventory is $2.4 billion (2023), against an average of $2.3 billion.
  • The largest annual shift saw Inventory dropped 5.67% in 2021 before it soared 33.05% in 2023.
  • A 5-year view of Inventory shows it stood at $1.6 billion in 2021, then increased by 15.96% to $1.9 billion in 2022, then soared by 33.05% to $2.5 billion in 2023, then rose by 13.12% to $2.8 billion in 2024, then grew by 4.73% to $2.9 billion in 2025.
  • Per Business Quant, the three most recent readings for BSX's Inventory are $2.9 billion (Q4 2025), $2.9 billion (Q3 2025), and $2.9 billion (Q2 2025).